We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

28 hedge funds and large institutions have $1.1M invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2014 Q2 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+28
Holders Change %
–
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$365K
2
U
UBS
Switzerland
+$292K
3
KCM
Knoll Capital Management
Florida
+$240K
4
VKH
Virtu KCG Holdings
New York
+$105K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$97.7K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$262K +$365K +304,389 New
U
2
UBS
Switzerland
$210K +$292K +243,657 New
KCM
3
Knoll Capital Management
Florida
$172K +$240K +200,000 New
VKH
4
Virtu KCG Holdings
New York
$76K +$105K +88,026 New
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$70K +$97.7K +81,500 New
LPL Financial
6
LPL Financial
California
$39K +$54.2K +45,200 New
Creative Planning
7
Creative Planning
Kansas
$27K +$37.6K +31,400 New
AIG
8
American International Group
New York
$23.5K +$32.8K +27,350 New
PCM
9
Princeton Capital Management
New Jersey
$22K +$30K +25,000 New
BRWA
10
B. Riley Wealth Advisors
Florida
$21.5K +$30K +25,000 New
PAG
11
Private Advisor Group
New Jersey
$19K +$25.9K +21,575 New
Citadel Advisors
12
Citadel Advisors
Florida
$19K +$26.1K +21,748 New
ACM
13
Academy Capital Management
Texas
$17K +$24K +20,000 New
Brown Advisory
14
Brown Advisory
Maryland
$17K +$24K +20,000 New
MFBTD
15
MB Financial Bank - Trust Department
Illinois
$17K +$24K +20,000 New
Bank of Montreal
16
Bank of Montreal
Ontario, Canada
$14K +$20.4K +17,000 New
LTFS
17
Ladenburg Thalmann Financial Services
Florida
$12K +$17K +14,200 New
Deutsche Bank
18
Deutsche Bank
Germany
$12K +$17.4K +14,500 New
RHBC
19
R.H. Bluestein & Co
Michigan
$9K +$12K +10,000 New
Bank of America
20
Bank of America
North Carolina
$9K +$12.6K +10,530 New
Janney Montgomery Scott
21
Janney Montgomery Scott
Pennsylvania
$8.6K +$12K +10,000 New
Wells Fargo
22
Wells Fargo
California
$7K +$9.59K +8,001 New
Morgan Stanley
23
Morgan Stanley
New York
$5K +$6.62K +5,520 New
GT
24
Glenmede Trust
Pennsylvania
$4K +$5.99K +5,000 New
TIM
25
Tortoise Investment Management
New York
$2K +$2.4K +2,000 New
1
2

PVCT Hedge Fund Activity: Q2 2014 in Review

28 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q2 2014, worth a combined $1.1M.

Buyers outnumbered sellers: 28 funds opened new PVCT positions and 0 closed out — a net gain of 28 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $365K.

  • 28 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q2 2014, up from 0 in Q1 2014.
  • Funds reported $1.1M of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q2 2014.
  • 28 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q2 2014 and 0 closed out, a net change of +28 holders.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q2 2014 was Goldman Sachs, an estimated $365K added.

Based on aggregated 13F filings for Q2 2014.